SHR-5421
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 31, 2026
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=97 | Recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Multiple Myeloma • Oncology
June 18, 2026
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=97 | Not yet recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 2
Of
2
Go to page
1